NCT02458547

Brief Summary

Despite many previous studies, whether anesthetic technique will significantly affect overall patient outcome, morbidity and mortality in elderly hip fracture patients is controversial. Due to old age, poor patient condition and emergent clinical settings, patients undergoing surgical procedures for hip fracture management are often subject to poor postoperative outcome and high mortality rates. While many studies have reported that regional anesthesia leads to improved postoperative outcome after hip fracture surgery, others have concluded otherwise. Moreover, because the majority of these previous studies are retrospective cohorts or systemic reviews, there is a need for randomized clinical trials to provide high quality evidence. This study aims to compare patient outcome between three different anesthetic techniques in elderly patients undergoing surgery for hip fracture management by evaluating proinflammatory cytokines, chemistry lab testing and clinical outcome between general anesthesia with either desflurane or propofol-based TIVA and spinal anesthesia with bupivacaine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
186

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2015

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

May 26, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 1, 2015

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 21, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 21, 2019

Completed
Last Updated

March 19, 2019

Status Verified

March 1, 2019

Enrollment Period

3.7 years

First QC Date

May 26, 2015

Last Update Submit

March 15, 2019

Conditions

Outcome Measures

Primary Outcomes (10)

  • HMGB1

    from preoperative baseline to 72hours

  • IL-6

    from preoperative baseline to 72hours

  • NT-proBNP

    from preoperative baseline to 72hours

  • hemoglobin

    from preoperative baseline to 72hours

  • total lymphocyte count

    from preoperative baseline to 72hours

  • albumin

    from preoperative baseline to 72hours

  • creatinine

    from preoperative baseline to 72hours

  • potassium

    from preoperative baseline to 72hours

  • troponin-T

    from preoperative baseline to 72hours

  • CRP

    from preoperative baseline to 72hours

Study Arms (3)

Group D

EXPERIMENTAL

General anesthesia with desflurane

Drug: Desflurane

Group P

ACTIVE COMPARATOR

General anesthesia with propofol total intravenous anesthesia

Drug: Propofol

Group S

ACTIVE COMPARATOR

Spinal anesthesia with 0.5% bupivacaine

Drug: Bupivacaine

Interventions

Inhalation anesthesia with desflurane at age-adjusted MAC of 0.8\~1.0

Group D

Total intravenous anesthesia with propofol target controlled infusion

Group P

Spinal anesthesia with 0.5% bupivacaine

Group S

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • \. Patients older than 65 years scheduled for elective or emergency hip fracture surgery.

You may not qualify if:

  • Patient refusal
  • Inflammation or wound at puncture site, increased intracranial pressure, bleeding diathesis
  • Allergies to propofol or its ingredients, soybeans or peanuts
  • Patients with altered mental status
  • Illiterate patients or foreigners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University Health System

Seoul, 120-752, South Korea

Location

MeSH Terms

Conditions

Hip Fractures

Interventions

DesfluranePropofolBupivacaine

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Intervention Hierarchy (Ancestors)

Ethyl EthersEthersOrganic ChemicalsMethyl EthersHydrocarbons, FluorinatedHydrocarbons, HalogenatedHydrocarbonsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicAnilidesAmidesAniline CompoundsAmines

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 26, 2015

First Posted

June 1, 2015

Study Start

May 1, 2015

Primary Completion

January 21, 2019

Study Completion

January 21, 2019

Last Updated

March 19, 2019

Record last verified: 2019-03

Locations